BIO-GENE TECHNOLOGY (BGT) Shares

ABOUT BIO-GENE TECHNOLOGY

Bio-Gene Technology Limited is an Australian AgTech company that seeks to address the global problem of insecticide resistance and toxicity.

To this end, the company has developed a novel technology platform based on the naturally occurring class of plant compounds known as beta-triketones, which have demonstrated insecticidal activity in testing performed to date. The insecticidal activity of this beta-triketone chemical class was first discovered following a botanical screening program looking to identify natural product-based insecticides in Australian flora.

The company is working on broadening its product portfolio with the development of two products targeted at different sectors of the insecticide market.

The first product, Flavocide, is a chemically synthesised product based on flavesone, a nature identical compound found in plants of the family Myrtaceae that includes myrtles and eucalypts.

The second product, Qcide, is derived from a natural oil product containing tasmanone as the main active constituent and extracted from the leaves of a rare cultivar of an Australian eucalypt, the Gympie Messmate (Eucalyptus cloeziana).

OVERVIEW OF BIO-GENE TECHNOLOGY

• The Bio-Gene Technology business strategy is focused on developing its technology in collaboration with multi-national partners across market sectors of animal health, crop protection as well as public health. The company works to generate revenues through fees received from partners in respect of their purchase of active materials, licence fees, payments made upon successful milestones in product development activity and royalties on sales.

• There are a limited number of novel insecticides coming to the market, of which the company has one of the few platforms that has potential appeal to the large players who are seeking new products to market separately and/or in combination with their increasingly older products. The potential speed to market benefit of collaborative partnerships allows the company to address the regulatory pathway in parallel to potentially shorten the time to registration.

• The company’s target markets include the global insecticide market, which is valued at USUS Dollar 31.1 billion. There are also a number of persistent drivers supporting the long-term demand for the global insecticide market, including increasing food and fiber requirements, protection of an increasingly urban population against pests and diseases, and the proliferation of certain insects due to climate change.

VISION & VALUES OF BIO-GENE TECHNOLOGY

• Bio-Gene Technology acknowledges its role within society and believes its success will deliver long-term positive benefits to all stakeholders.

• The company’s corporate governance principles and code of conduct set the framework for how the company, management and employees are expected to conduct themselves: always ethically and responsibly.

• The very nature of the company’s products affords the opportunity of changing lives for the better. Through innovative research and development, the company is creating products for needs which are currently unmet.

• All of the company’s research activities strive to comply with strict regulatory and ethical approval processes.

MARKET PERFORMANCE OF BIO-GENE TECHNOLOGY

• Bio-Gene Technology Limited trades on the Australian Securities Exchange (ASX), where investors can buy shares under the stock symbol –BGT.

• Data from the company’s 2019 financial analysis shows total revenue including other income during the period was US Dollar 644 million, up from US Dollar 474 million in 2018. This revenue included an estimated R&D Tax Incentive of US Dollar 505 million, interest of US Dollar 135 million, and Licence Fees of US Dollar 2.8 million.

• The company’s ongoing investment in its product portfolio, which is developed to target a largely unmet market with a history of high demand, is set to deliver a flourishing share price for investors with solid long-term growth in dividends, securing a solid buy-in for those who choose to purchase shares today.

Buy BIO-GENE TECHNOLOGY stocks / shares – A Step by Step Guide how to Buy / Purchase BIO-GENE TECHNOLOGY Stocks or Shares online.

Before buying any stock or share one has to consider a few factors.

STEP 1: PROPER RESEARCH IS ESSENTIAL

Upon deciding you want to buy BIO-GENE TECHNOLOGY Stocks / Shares, it is critical for the serious investor to do proper research into the said company. Its values should align with those of the investor’s current portfolio. An investor needs to familiarise himself with the basics and history of the company, as well as its leadership and performance in the market. Its company reports should also be scrutinized.

Consultation with a brokerage firm can also assist in determining whether investing in a specific company will complement the investor’s current portfolio. The investment “risk ladder”, which identifies asset classes based on their relative riskiness, is another useful tool when determining which company’s stock / share is the best to buy.

STEP 2: CALCULATE THE AMOUNT OF INVESTMENT IN BIO-GENE TECHNOLOGY STOCKS / SHARES

It is important for an investor to monitor his total investment in stock in order to keep his portfolio aligned to his investment strategy. The overall value of his holdings will change with the fluctuation in stock prices, which can throw his portfolio off balance. To determine the amount to invest, multiply the number of shares of each stock by its current market price to determine the total investment in that specific stock. For example, if you own 100 shares of a US Dollar 5 stock, multiply 100 by US Dollar 5 to get US Dollar 500.

STEP 3: DECIDE ON THE STOCK / SHARE ORDER TYPE

Investors can choose from a market order, a limit order, a stop order (also referred to as a stop-loss order) or a buy/sell stop order. It is important to familiarise yourself with each type’s pros and cons before deciding which one will suit your current stock profile best. An investor should be guided in this choice by his investment objective.

STEP 4: OPEN A BROKERAGE ACCOUNT

A brokerage account – also known as taxable investment account – is similar to a retirement account, but more flexible. Where a retirement account has limitations on the amount of money that can be contributed annually, and restrictions on when funds can be withdrawn, a brokerage account is more flexible. The latter has no income or contribution limit and the investor can withdraw his money at any given time. This flexibility, together with its potential investment gains, makes a brokerage account more attractive to serious investors. Brokerage accounts are ideal for goals or savings that are further than five years away, but closer than retirement. It can also supplement an investor’s emergency savings.

STEP 5: COMMIT AND PURCHASE BIO-GENE TECHNOLOGY STOCKS / SHARES

Lastly, commit to the stock. Pro Tip: Monitor the value of your stock to ensure you have a growing stock value and dividend pay-out.  Regularly check the share price online to ensure your investment delivers a positive return on investment. You are now a proud owner of BIO-GENE TECHNOLOGY stocks / shares.

5 Questions to ask yourself before purchasing any stocks or shares.

1. Is it the best time to buy this stock / share?
2. Should I buy BIO-GENE TECHNOLOGY stocks / shares in the current economic climate?
3. Can I afford to buy this stock / share?
4. What is the forecast of the stock / share growth?
5. What is the current price per earning ration on the stock / share?